Robot-Assisted Surgical Systems Market: Market Opportunities, Competitive Landscape, Segmentation, Analysis & Forecast 2023

 Market Highlights

It is estimated that the Global Robot-Assisted Surgical Systems Market is expected to register a CAGR of 10% during the forecast period of 2018 to 2023.

Robot-assisted surgical systems industry will witness a widespread adoption since the introduction of the da Vinci surgical system by Intuitive Surgical Inc. After the system got FDA approval in 2000, da Vinci surgical system became the most widely-used surgical robot in the United States and Europe helping many cases to witness reduced length of hospital stays and lower rates of infection.

The increasing need for automation in the healthcare industry and the shifting trend towards advanced robotic surgeries is anticipated to fuel the growth of the market. The high initial costs and adverse reports stand is expected to hamper the growth of the market.

The global robot-assisted surgical systems market is conquered by several players. The key players are involved in new product launches, as well as strategic collaborations to brace their position in the market. For instance, in May 2015, Medtech expanded its presence in Asia with the sales of three ROSA Surgical Robots during April. This initiative is anticipated to open new avenues for the firm to cater to the untapped markets in this region.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/7777

Regional Analysis

The Americas is expected to hold a major share in the global robot-assisted surgical systems market can be attributed to the surgeon’s preference for laparoscopy over open surgeries, due to the reduced blood loss, minimal scarring, shorter hospital stays, and rapid recovery times.

Europe is expected to hold the second largest share in the robot-assisted surgical systems market owing to the approval of the da Vinci X system developed by Intuitive Systems in Europe. The company’s primary aims of modeling this system were to make use of the most advanced robot-assisted surgery technologies at a lower cost. This is expected to increase the market for Intuitive’s surgical robots in European countries.

Asia-Pacific was projected to be the fastest growing region for the global robot-assisted surgical systems market due to the high adoption of HCIT technologies, regulatory requirements regarding patient safety. The Middle East and Africa holds the least share in the market due to fewer initiatives taken by the government.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/robot-assisted-surgical-systems-market-7777

Segmentation

The global robot-assisted surgical systems market is segmented on the basis of product, application, and end user.

The robot-assisted surgical systems market by product is categorized into surgical robots, rehabilitation robots, non-invasive radiosurgery robots, hospital and pharmacy robots, and emergency response robotic systems.

Surgical robots are divided into orthopedic surgical robots, robotic neurosurgical systems, and laparoscopy robotic systems. Orthopaedic Surgical Robots is divided into iBlock surgical system, Robodoc surgical system, Navio PFS surgical system, MAKO RIO surgical system, and Stanmore Sculptor surgical system. Neurosurgical Robotic Systems is divided into Pathfinder surgical system, NeuroMate surgical system, and Renaissance surgical system. Laparoscopy Robotic Systems is divided into FreeHand endoscope holder system, Da Vinci robotic surgery system, Telelap ALF-X surgical system, and Steerable Robotic Catheters.

Rehabilitation robots are categorized into assistive robots, prosthetics, orthotics, therapeutic robots, and robotic exoskeleton systems. Hospital and pharmacy robots are categorized into telemedicine robots, IV robots, pharmacy robots, and cart transportation robots.

Based on application, the robot-assisted surgical systems market is segmented into neurology, orthopedics robotic systems, laparoscopy, and special education.

On the basis of end user, the market is segmented into healthcare providers, healthcare payers, and others.

Key Players

Some of the key players in the global robot-assisted surgical systems market are Stryker Corporation (MAKO Surgical Corp.), Renishaw Plc, Varian, Accuray, Intuitive Surgical Inc, Health robotics S.R.L, Smith & Nephew Plc. (Blue Belt Technologies, Inc.), Auris Surgical Robotics, Inc. (Hansen Medical Inc.), KUKA AG, Mazor Robotics, Medtronic plc, THINK Surgical Inc., Zimmer Biomet Holdings Inc., Transenterix, Verb Surgical, Titan Medical, Microbot Medical, Medrobotics

Medical Billing Outsourcing Market: Emerging Technologies, Competition & Strategies of Key Players, Regional Analysis and Forecast By 2023

 

Market Highlights

The global Medical Billing Outsourcing Market is expected to grow at an approximate CAGR of 12.5% during the forecast period, 2018–2023.

The growing emphasis on compliance and risk management and global expansion of some of the key players are some of the key factors driving the medical billing outsourcing market. In 2016, Allscripts acquired Core Medical Solutions, to increase its offerings in Australia. Allscripts currently supports more than 85 hospitals throughout Australia.

Various other factors such as rising healthcare expenditure, increasing government support, and technological advancements are also expected to propel the growth of the market.

However, increasing legislative & regulatory pressure, untapped emerging markets, and high costs of technology can hamper market growth over the forecast period.

Segmentation

The global medical billing outsourcing market is segmented based on product, material type, application, end user, and region.

The global market for medical billing outsourcing, by component, is segmented into outsourced and in-house. The outsourced segment is anticipated to hold the largest market share owing to the rising adoption of medical billing software by hospitals.

Based on service, the market is segmented into front end, middle, and back end. The front-end services, usually, includes preregistration, registration, eligibility, scheduling, pre-authorization, etc. Due to the market saturation, front-end services segment is facing decline.

Based on end user, the market is segmented into hospitals, physician’s office, and others. The hospitals segment is expected to hold the largest market share due to rising cases of diseases.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/7621 

Regional Analysis

The Americas dominated the global market for medical billing outsourcing owing to the increasing healthcare expenditure, the presence of major market players, and rising adoption of medical billing outsourcing software by the hospitals within the region. It was found that around 80% of hospitals considering outsourcing full revenue cycle management by 2019. Moreover, in 2018, AdvancedMD announced the availability of ePayments, which facilitates to collect outstanding patient balances and reduce aging A/R more quickly and conveniently.

In 2017, it was estimated that Europe stood second in the global medical billing outsourcing market. This can be attributed to the increasing need to make billing processes efficient.

Asia-Pacific was the fastest growing region in 2017. Emerging economies, such as Singapore, Australia, India, and China, are the most lucrative markets due to the increasing patient pool and improving healthcare facilities. The increasing awareness about medical billing software and their growing importance coupled with the supportive government programs and policies are going to boost up the market.

On the other hand, the Middle East and Africa held the least share in the global medical billing outsourcing market due to the lack of healthcare awareness, and lack of advanced technology. However, Saudi Arabia and the UAE lead in terms of market shares in this region because of a good economy, skilled medical professionals, and accessibility to modern technology thus, contributing to the steady growth of the market in the Middle Eastern and African region.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/medical-billing-outsourcing-market-7621

Key Players

Some of the key players in the global medical billing outsourcing market are R1 RCM Inc., Allscripts, Cerner Corporation, EClinical Works, Experian Information Solutions Inc., GENERAL ELECTRIC COMPANY, Genpact, HCL Technologies Limited, Kareo, Inc., McKesson Corporation, Quest Diagnostics Incorporated, The SSI Groups Inc, and others.

Medical Carts Market Global Size, Future Scope, Demands and Projected Industry Growths to 2023

  Market Scenario

Global Medical Carts Market is expected to grow significantly over the forecast period. The market held a market value of USD 1,100 million in 2017 and is projected to grow at a CAGR of 12.1% over the forecast period.

The growing acceptance of medical carts accustomed by its technical advances is one of the major trends witnessed in the global medical carts market over the forecast period.

According to world health organization, musculoskeletal conditions are the second largest contributor to disability globally. Musculoskeletal conditions include conditions that affect joints (psoriatic arthritis, gout, osteoarthritis, rheumatoid arthritis), bones (osteoporosis, osteopenia and associated fragility fractures), and muscles (sarcopenia).

Other key factors such significant investments in R&D and expansions undertaken by key players are contributing towards the growth of the market. However, challenges such as high cost of advanced medical carts in developing countries, is likely to curb the market growth during the forecast period.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/7436 

Segmentation

The global medical carts market is segmented based on product type, type, material type, and end-users.

The medical carts market, by product type, the market is segmented into mobile computing carts, medical storage columns, wall-mounted workstations, medication carts, and others.

Based on type, the market is segmented into computer medical cart, procedure cart, emergency cart, anaesthesia cart, and others.

Based on material type, the market is segmented into metal type, plastic type, and others.

Based on end-user, the market is segmented into hospitals and clinics, ambulatory surgical centres, and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/medical-carts-market-7436  

Regional Analysis

The Americas is the largest in the market owing to the improving research infrastructure in the region, coupled with the rising awareness among patients and physicians. It is currently exhibiting a highly lucrative growth rate due to an increased use of medical carts for various applications.

The European region is the second largest medical carts market over the forecast period due to high acceptance of medical carts in developing countries along with the rising incidence of chronic diseases are also accountable for the growth of the medical carts market.

The Asia Pacific region is likely to develop at the uppermost CAGR for the medical carts market in the years to come. Moreover, the rising patient safety at the hospitals and at community level are expected to influence the market in a positive way.

The Middle East and Africa accounts for the least market share due to low per capita income and lack of availability of well-trained healthcare professionals.

Key Players

Some of the key players in the global medical carts market are ITD GmbH (Germany), Advantech Co. (Taiwan) Ltd, Harloff Manufacturing Co. (US), AFC Industries (US), Chang Gung Medical Technology Co. (Taiwan), Omnicell Inc. (US), Midmark Corporation (US), The Bergmann Group (US), Capsa Healthcare (US), Jaco Inc (US), Waterloo Healthcare (US), Ergotron Inc (US) and others.

In Cell Surface Markers Market to Incur Rapid Extension During 2017-2023

 

Market Highlights

The global Cell Surface Markers Market is anticipated to hold a market value of USD 498 million in the year 2017 and is expected to grow at a CAGR of 8.4% during the forecast period. Cell surface markers or cell surface antigen work as monograms for identification and classification of cells. The proteins that are expressed on the cell surfaces often conveniently work as markers for specific types of cells.

Increasing expenditure in the advancement of healthcare technology, advancement in technology, acquisitions by companies and outlook for reduction of costs associated with disease diagnosis are expected to drive the growth in the market over the forecast period. For instance, in April 2014, Beckman Coulter, acquired Xitogen Technologies, a cytometer manufacturer. This acquisition helped Beckman Coulter to broaden its product offerings and enabled business expansion in Asia. However, complex products and expensive instruments & reagents can restrain the market growth over the assessment period.

Regional Analysis

Geographically, the Americas is expected to dominate the global market owing to the significant amount of research and development activities and well-developed healthcare infrastructure. According to the Organization for Economic Co-operation and Development(OECD), In 2016 united states has spent USD 464,324 million on research and development activities which is 2.7% of total GDP. Europe is expected to hold the second largest position in the global market owing to the well-developed healthcare infrastructure. Asia-Pacific is expected to be the fastest growing market owing to the growing demand for user friendly targeted therapies. Moreover, the Middle East and Africa region is expected to account for the least market share in the global market.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/cell-surface-markers-market-7410

Segmentation

The global cell surface markers market has been segmented into product, source, cell type and application.

The market, on the basis of product, has been segmented into antibody and PCR array.

The global market, on the basis of source, has been segmented into mice, rat and others.

The global market, on the basis of cell type, has been segmented into T cells, B cells and NK cells. T cells are expected to hold the largest market share owing to high usage of them in research and diagnostics. NK cells are expected to grow at the fastest CAGR owing to increasing application of these types of cell.

The global cell surface markers market, by application, has been segmented into research, clinical and others. Research segment has been further divided into stem cell and immunology. Clinical segment is further divided into oncology and hematology.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/7410

Key Players

Some of the prominent players in the global cell surface markers market are Bio-Rad Laboratories, Inc., Abbott, Siemens Healthcare Private Limited, Beckman Coulter, Inc. , F. Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION, Thermo Fisher Scientific, BD, Abcam plc., QIAGEN, Danaher, GenScript, Merk KGaA, BioLegend, Inc., Cell Signaling Technology, Inc., Bio-Techne and Others.